Sun Pharma gets USFDA nod for plaque psoriasis drug Industry-The Economic Times — March 21, 2018 comments off The FDA approval of the drug was supported by data from the pivotal phase-3 resurface clinical development program, it said.
The FDA approval of the drug was supported by data from the pivotal phase-3 resurface clinical development program, it said.